Kazazian Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,108
Closed -$372K 67
2018
Q4
$372K Sell
5,108
-7,006
-58% -$495K 0.5% 35
2018
Q3
$820K Hold
12,114
0.77% 33
2018
Q2
$702K Sell
12,114
-454
-4% -$25.6K 0.64% 34
2018
Q1
$653K Hold
12,568
0.68% 34
2017
Q4
$675K Buy
12,568
+346
+3% +$19.2K 0.69% 34
2017
Q3
$747K Buy
12,222
+5,045
+70% +$306K 0.91% 26
2017
Q2
$439K Buy
+7,177
New +$437K 0.66% 30
2016
Q1
Sell
-5,177
Closed -$261K 66
2015
Q4
$261K Sell
5,177
-18,852
-78% -$950K 0.35% 34
2015
Q3
$1.13M Buy
24,029
+2,493
+12% +$132K 1.43% 16
2015
Q2
$1.17M Buy
21,536
+13,676
+174% +$767K 1.16% 16
2015
Q1
$431K Buy
+7,860
New +$445K 0.57% 35

Other funds holding MRK

Kazazian Asset Management's MRK Position: Q1 2019 in Review

Kazazian Asset Management sold out of Merck (MRK) in Q1 2019, closing a stake of 5,108 shares — an estimated $372K sold.

Kazazian Asset Management first reported a position in MRK in Q1 2015 and held it in 11 quarters. The position peaked at $1.17M in Q2 2015. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

  • Kazazian Asset Management reported no remaining Merck position as of Q1 2019 after selling out during the quarter.
  • Kazazian Asset Management sold 5,108 Merck shares in Q1 2019, an estimated $372K.
  • Kazazian Asset Management first reported a position in Merck in Q1 2015 and held it in 11 quarters.
  • Kazazian Asset Management's Merck position peaked at $1.17M in Q2 2015.
  • 2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Kazazian Asset Management's 13F filing for Q1 2019, filed 15 May 2019.